Ruchika Chitravanshi, Sohini Das &Amp;Amp; Sachin Mampatta

Stories by Ruchika Chitravanshi, Sohini Das &Amp;Amp; Sachin Mampatta

50 Mn To 100 Mn Indians Suffer From Long Covid

50 Mn To 100 Mn Indians Suffer From Long Covid

Rediff.com   3 days ago

Even by conservative assumptions that 5 to 10 per cent of infected individuals develop long Covid, India today may be home to 50 to 100 million infected individuals -- many silently coping with breathlessness, fatigue, palpitations, brain fog, or unexplained clotting tendencies.

IMFreport: 'Zombie firms' reflect inefficient insolvency resolution

IMFreport: 'Zombie firms' reflect inefficient insolvency resolution

Rediff.com   7 days ago

The International Monetary Fund, in its report on the Indian economy, said the Insolvency and Bankruptcy Code (IBC) Amendment Bill addresses many deficiencies but it has not provided for the participation of operational creditors or rules for executory contracts. The IMF staff report said that the business dynamism in India remains relatively low, marked by low rates of entry and exit, and a high share of inactive or inefficient firms reflecting structural rigidities and high compliance levels.

GST 2.0 bolstered momentum, economy on stable footing

GST 2.0 bolstered momentum, economy on stable footing

Rediff.com   7 days ago

The reduction in the goods and services tax (GST) rates has increased the momentum in India's economic activity both on the supply and demand sides, while robust agricultural activity - reflected in the strong onset of rabi sowing and adequate reservoir levels - has reinforced the outlook for food supply and rural incomes, the finance ministry said on Thursday.

India rejects IMF view that US tariffs will stay indefinitely, hit growth

India rejects IMF view that US tariffs will stay indefinitely, hit growth

Rediff.com   27 Nov 2025

The Indian government has expressed its disagreement with the IMF staff's 'baseline' assumption that the 50 per cent US tariffs on its goods exports 'would remain in place indefinitely', based on which the staff pegged the country's GDP growth at 6.6 per cent this year, and pared its 2026-27 projection by 20 basis points to 6.2 per cent.

India on track to surpass $4 trn GDP in FY26: CEA

India on track to surpass $4 trn GDP in FY26: CEA

Rediff.com   26 Nov 2025

India is on track to exceed the $4 trillion milestone in 2025-26 (FY26), surpassing the $3.9 trillion gross domestic product (GDP) mark recorded at the end of March 2025, Chief Economic Adviser (CEA) V Anantha Nageswaran said on Tuesday.

Haircuts in cases resolved under IBC at 67% till Sep

Haircuts in cases resolved under IBC at 67% till Sep

Rediff.com   24 Nov 2025

Creditors took a haircut of around 67 per cent on their admitted claims on the realisation made till September 2025 under the corporate insolvency resolution process (CIRP) of the Insolvency and Bankruptcy Code (IBC), the latest data released by the insolvency regulator showed.

'Confident of good trade deal with US'

'Confident of good trade deal with US'

Rediff.com   21 Nov 2025

Officials from both India and the US in the recent past have indicated that a "fair deal" will be concluded soon, with Indian officials holding that more formal rounds of talks are not needed.

Seniors to Drive 25% of India's Pharma

Seniors to Drive 25% of India's Pharma

Rediff.com   21 Nov 2025

'Once the 60-plus population hits 20 to 30 per cent of the country, the demand for elderly-care treatments will surge -- cardiac, metabolic, neurological, and musculoskeletal medicines are going to dominate the market for the next several decades.'

EAC-PM chair calls for raising investment rate

EAC-PM chair calls for raising investment rate

Rediff.com   20 Nov 2025

India needs to increase the investment rate to 34-35 per cent from 31-32 per cent currently to achieve a growth rate of 7 per cent and above, said S Mahendra Dev, chairman, economic advisory council (EAC) to the Prime Minister, on Wednesday.

Pune Firm Unveils Diabetes-Control Implant

Pune Firm Unveils Diabetes-Control Implant

Rediff.com   19 Nov 2025

This innovation works by stimulating our natural organs so that it can produce and maintain the insulin balance.

MCA Rethinks PM Internship Scheme

MCA Rethinks PM Internship Scheme

Rediff.com   17 Nov 2025

With less than six months left for this financial year and poor response from applicants, launching the scheme this year is unlikely.

Supply chains face stress test amid trade shifts: PwC India

Supply chains face stress test amid trade shifts: PwC India

Rediff.com   17 Nov 2025

Supply chains are evolving from operational backbones to strategic growth enablers for organisations, though they remain underleveraged and struggle for recognition at the executive level, a report by PwC India said. The survey highlighted that recent developments in the trade and tariff landscape represent both a stress test and a strategic inflection point for supply chains.

Inefficiency in MFIs leads to high interest rates: DFS secretary M Nagaraju

Inefficiency in MFIs leads to high interest rates: DFS secretary M Nagaraju

Rediff.com   14 Nov 2025

The reduction in the number of loan accounts and the outstanding amount during the last financial year is a cause of concern and stress for microfinance institutions (MFI), Secretary, Department of Financial Services, M Nagaraju said on Thursday, highlighting "inefficiency" in MFIs that leads to higher rates of interest.

VinFast Outsells Tesla in Festival Season But BYD Is King

VinFast Outsells Tesla in Festival Season But BYD Is King

Rediff.com   10 Nov 2025

Vinfast sold 137 cars versus Tesla's 109 during the festive months of September and October, as BYD maintained a strong lead with over 1,100 cars sold, according to Fada data.

USFDA's new draft biosimilar rules to benefit Indian biotech cos

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Rediff.com   9 Nov 2025

The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.

Bajaj Auto posts highest ever quarterly revenue and PAT

Bajaj Auto posts highest ever quarterly revenue and PAT

Rediff.com   8 Nov 2025

Pune-based two-wheeler major Bajaj Auto posted its highest ever quarterly revenue and profit after tax (PAT) in Q2FY26. Even as consolidated revenues were up 18.8 per cent year-on-year (Y-o-Y) to Rs 15,734.7 crore, PAT zoomed 53.2 per cent to Rs 2,122 crore.

Road, rail, ministries cross halfway mark in capex spending till Sep

Road, rail, ministries cross halfway mark in capex spending till Sep

Rediff.com   6 Nov 2025

The ministries of Road Transport & Highways and Railways have exceeded the national average capital expenditure (capex) by spending 63 per cent and 57 per cent of Budget estimates (BE), respectively, in the first half of 2025-26 (FY26). The total capital expenditure for April-September of FY26 stood at 52 per cent of the BE, according to the latest data by the Controller General of Accounts (CGA).

IBBI ends 'going concern' sales under liquidation

IBBI ends 'going concern' sales under liquidation

Rediff.com   28 Oct 2025

IBBI removes sale of company as going concern in liquidation; now only asset sales allowed, shifting focus strictly to terminal liquidation process.

Where The Deadly Cough Syrup Was Made

Where The Deadly Cough Syrup Was Made

Rediff.com   18 Oct 2025

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up. The non-descript two-room building is a manufacturing unit of Sresan Pharmaceuticals, the pharma company made its Coldriff cough syrup that has allegedly killed 25 children in Madhya Pradesh.

Electric PV sales more than double in September; Tata Motors leads

Electric PV sales more than double in September; Tata Motors leads

Rediff.com   9 Oct 2025

Electric passenger vehicle (PV) retail sales jumped more than twofold in September with Tata Motors (TaMo) leading the pack having over 6,000 registrations and a 40 per cent market share.